Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus

Background Depression is a common neuropsychiatric symptom in Parkinson's disease (PD). In previous research, PD-related depression was associated with striatal dopaminergic deficits, presumably due to degeneration of brainstem dopaminergic projections. Segregated areas of the striatum are crucially involved in various parallelly arranged cortical-striatal-thalamocortical circuits and serve functions in, among others, motor control or emotion. This suggests regional specificity of dopaminergic deficits in the striatum in motor and depressive symptoms in PD. Methods In this cross-sectional retrospective study, we correlated severity scores of depressive and motor symptoms in 100 non-demented PD patients (median Hoehn & Yahr stage: 2) with dopamine loss in specific regions of the striatum as measured by [123I]FP-CIT SPECT tracer binding to the dopamine transporter (DaT). Results Depressive symptoms were related to lower DaT binding in the right caudate nucleus, while motor symptoms were associated with decreased DaT binding in the right putamen. This double dissociation was most pronounced in early-stage PD patients. Conclusions These results suggest that depressive symptoms in PD are associated with dopamine loss in the caudate nucleus, possibly related to degeneration of dopaminergic projections from the ventral tegmental area, while motor symptoms are associated with low dopamine signalling to the putamen and loss of nigrostriatal projections. This is consistent with the neuroanatomy of partially segregated cortical-striatal-thalamocortical circuits and supports the role of dysfunctional associative and motivational circuits in PD-related depression.

[1]  P. Rabins,et al.  A comparison of nine scales to detect depression in Parkinson disease , 2012, Neurology.

[2]  Jan Booij,et al.  Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  S. Haber,et al.  The cortico-basal ganglia integrative network: The role of the thalamus , 2009, Brain Research Bulletin.

[4]  J. Price,et al.  Neural circuits underlying the pathophysiology of mood disorders , 2012, Trends in Cognitive Sciences.

[5]  Kuei Yuan Tseng,et al.  Handbook of basal ganglia structure and function , 2010 .

[6]  J. Kulisevsky,et al.  Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[7]  H. Berendse,et al.  Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study , 2013, Neurobiology of Aging.

[8]  W. Pirker,et al.  Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? , 2003, Movement disorders : official journal of the Movement Disorder Society.

[9]  A. Björklund,et al.  Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson’s Patients Treated with Dopamine Grafts , 2012, Science Translational Medicine.

[10]  I. Katz,et al.  Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[12]  Johannes Schwarz,et al.  Monoamine transporter availability in Parkinson’s disease patients with or without depression , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  H. Mayberg,et al.  Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease , 1990, Annals of neurology.

[14]  W. Poewe,et al.  The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[15]  P. Boesiger,et al.  Imbalance between Left and Right Dorsolateral Prefrontal Cortex in Major Depression Is Linked to Negative Emotional Judgment: An fMRI Study in Severe Major Depressive Disorder , 2008, Biological Psychiatry.

[16]  Jeffrey L. Birk,et al.  Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. , 2009, The American journal of psychiatry.

[17]  S. Leh,et al.  Fronto-striatal connections in the human brain: A probabilistic diffusion tractography study , 2007, Neuroscience Letters.

[18]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[19]  Oded Gonen,et al.  Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. , 2007, The American journal of psychiatry.

[20]  A. Lees,et al.  Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.

[21]  D J Wyper,et al.  Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake , 2000, Movement disorders : official journal of the Movement Disorder Society.

[22]  Irena Rektorova,et al.  Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[23]  Nora Turjanski,et al.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. , 2005, Brain : a journal of neurology.

[24]  K. L. Leenders,et al.  Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson’s disease , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  Dag Aarsland,et al.  Depression in Parkinson disease—epidemiology, mechanisms and management , 2011, Nature Reviews Neurology.

[26]  H. Groenewegen,et al.  The Ventral Striatum as an Interface Between the Limbic and Motor Systems , 2007, CNS Spectrums.

[27]  H. Groenewegen,et al.  Organization of Prefrontal-Striatal Connections , 2010 .

[28]  C. Hawkes The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it? , 2008, Movement disorders : official journal of the Movement Disorder Society.

[29]  E. Bézard,et al.  Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats , 2008, Neuroscience.

[30]  R. Bressan,et al.  Higher dopamine transporter density in Parkinson’s disease patients with depression , 2010, Psychopharmacology.

[31]  V. Haroutunian,et al.  The neuropathological basis for depression in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[32]  Z. Illés,et al.  Morphometric changes of gray matter in Parkinson's disease with depression: A voxel‐based morphometry study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[33]  L. Reneman,et al.  Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers , 2000, European Journal of Nuclear Medicine.

[34]  J. Weiss,et al.  Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum. , 2011, The international journal of neuropsychopharmacology.

[35]  M Filippi,et al.  Regional patterns of brain tissue loss associated with depression in Parkinson disease , 2010, Neurology.

[36]  Gal Yadid,et al.  VTA Dopamine Neuron Bursting is Altered in an Animal Model of Depression and Corrected by Desipramine , 2008, Journal of Molecular Neuroscience.

[37]  P. Pollak,et al.  The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson’s disease , 1999, Journal of the Neurological Sciences.

[38]  Gerty J. L. M. Lensvelt-Mulders,et al.  Brain volume abnormalities in major depressive disorder: A meta‐analysis of magnetic resonance imaging studies , 2009, Human brain mapping.

[39]  H. Rickards,et al.  Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.